Recommendations for performing thromboelastography/thromboelastometry in hemophilia: Communication from the SSC of the ISTH

Journal of Thrombosis and Haemostasis

Volumn 12, Issue 1, 2014, Pages 103-106

  Chitlur, M ^a   Rivard, G E ^b   Lillicrap, D ^c   Mann, K ^d   Shima, M ^e   Young, G ^f  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^b UNIVERSITY OF MONTREAL   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

^d UNIVERSITY OF VERMONT   (United States)

^e NARA MEDICAL UNIVERSITY   (Japan)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KAOLIN; RECOMBINANT THROMBOPLASTIN; THROMBOPLASTIN;

ARTICLE; BLOOD CELL COUNT; BLOOD CLOTTING; BLOOD CLOTTING PARAMETERS; BLOOD CLOTTING TIME; BLOOD COLLECTION TUBE; DILUTION; HEMOPHILIA; HUMAN; LABORATORY DEVICE; POLYMERIZATION; PRIORITY JOURNAL; STANDARDIZATION; THROMBOELASTOGRAPHY; THROMBOELASTOMETRY; TOURNIQUET; YOUNG MODULUS;

HEMOPHILIA A; HUMANS; THROMBELASTOGRAPHY;

EID: 84891893038     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12458     Document Type: Article

References (12)

1. Young G, Sorensen B, Dargaud Y, Negrier C, Brummel-Ziedins K, Key NS. Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state of art and future perspectives. Blood 2013; 121: 1944-50.
2. Young G, Zhang R, Miller R, Yassin D, Nugent DJ. Comparison of kaolin and tissue factor activated thromboelastography in haemophilia. Haemophilia 2010; 16: 518-24.
3. Viuff D, Andersen S, Sorensen BB, Lethagen S. Optimizing thrombelastography (TEG) assay conditions to monitor rFVIIa (NovoSeven) therapy in haemophilia A patients. Thromb Res 2010; 126: 144-9.
4. Luddington R, Baglin T. Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition. J Thromb Haemost 2004; 2: 1954-9.
5. Dargaud Y, Luddington R, Baglin TP. Elimination of contact factor activation improves measurement of platelet-dependent thrombin generation by calibrated automated thrombography at low-concentration tissue factor. J Thromb Haemost 2006; 4: 1160-1.
6. Riddell A, Abdul-Kadir R, Pollard D, Tuddenham E, Gomez K. Monitoring low dose recombinant factor VIIa therapy in patients with severe factor XI deficiency undergoing surgery. Thromb Haemost 2011; 106: 521-7.
7. Lippi G, Franchini M, Montagnana M, Salvagno GL, Poli G, Guidi GC. Quality and reliability of routine coagulation testing: can we trust that sample? Blood Coagul Fibrinolysis 2006; 17: 513-9.
8. Zambruni A, Thalheimer U, Leandro G, Perry D, Burroughs AK. Thromboelastography with citrated blood: comparability with native blood, stability of citrate storage and effect of repeated sampling. Blood Coagul Fibrinolysis 2004; 15: 103-7.
9. Sorensen B, Johansen P, Christiansen K, Woelke M, Ingerslev J. Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost 2003; 1: 551-8.
10. Sorensen B, Ingerslev J. Tailoring haemostatic treatment to patient requirements - an update on monitoring haemostatic response using thrombelastography. Haemophilia 2005; 11(Suppl 1): 1-6.
11. Young G, Ebbesen LS, Viuff D, Di Paola J, Konkle BA, Negrier C, Pasi J, Ingerslev J. Evaluation of thromboelastography for monitoring recombinant activated factor VII ex vivo in haemophilia A and B patients with inhibitors: a multicentre trial. Blood Coagul Fibrinolysis 2008; 19: 276-82.
12. Sorensen B, Persson E, Ingerslev J. Factor VIIa analogue (V158D/E296V/M298Q-FVIIa) normalises clot formation in whole blood from patients with severe haemophilia A. Br J Haematol 2007; 137: 158-65.